Molecular Insights and Clinical Outcomes of Drugs of Abuse Adulteration: New Trends and New Psychoactive Substances
Adulteration is a well-known practice of drug manufacturers at different stages of drug production. The intentional addition of active ingredients to adulterate the primary drug may enhance or mask pharmacological effects or may produce more potent drugs to increase the number of available doses and...
Main Authors: | Annagiulia Di Trana, Diletta Berardinelli, Eva Montanari, Paolo Berretta, Giuseppe Basile, Marilyn A. Huestis, Francesco Paolo Busardò |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-11-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/23/23/14619 |
Similar Items
-
New Psychoactive Substances Intoxications and Fatalities during the COVID-19 Epidemic
by: Alfredo Fabrizio Lo Faro, et al.
Published: (2023-02-01) -
Toxicology and Analysis of Psychoactive Tryptamines
by: Sara Malaca, et al.
Published: (2020-12-01) -
Editorial: Pharmacology of new psychoactive substances
by: K. Lutfy, et al.
Published: (2023-05-01) -
Quetiapine Abuse in Illicit Drug Users or Sellers: To Screen or Not to Screen?
by: İsmail Ethem Gören, et al.
Published: (2021-08-01) -
Exploring the topic structure and abuse trends of new psychoactive Substance since the 21st century from a bibliometric perspective
by: Xiaolong Hou, et al.
Published: (2024-04-01)